PREPARE
Top View
- Comparison and Analysis of Neutralizing Antibody Levels in Serum After Inoculating with SARS-Cov-2, MERS-Cov, Or SARS-Cov Vaccines in Humans
- Self-Assessment of COVID-19 Vaccination Efficacy Using a Lateral Flow Tests for SARS-Cov-2 S1 Protein Antibody
- Development of an Inactivated Vaccine Candidate, BBIBP-Corv, with Potent Protection Against SARS- Cov-2
- Key Informant Perceptions on Wildlife Hunting in India During the COVID-19 Lockdown
- Non-Pharmaceutical Public Health Measures for Mitigating the Risk And
- COVID-19 Vaccine Planning and Considerations
- (Coronavac) in Healthy Children and Adolescents: a Double-Blind, Randomised, Controlled, Phase 1/2 Clinical Trial
- Why Has COVID-19 Hit Different European Union Economies So Differently?
- Humoral Immune Response to Circulating SARS-Cov-2 Variants Elicited by Inactivated and RBD-Subunit Vaccines
- Access and Adoption Issues Associated with COVID-19 Vaccines
- COVID-19 Vaccination: Supply and Logistics Guidance
- Recommendations to Prepare for a Fall Surge of COVID-19 Cases Version: June 19, 2020
- Getting Ready for the COVID-19 Vaccine Rollout (ADB Brief 166)
- COVID-19 Vaccine Handling Toolkit: Operational Considerations for Healthcare Practitioners
- The Coronavirus Pandemic and Next Generation EU in the Baltic States1
- Characterizing Cellular and Molecular Variabilities of Peripheral Immune
- Pharmaceutical Interventions Against COVID-19
- • Dr. Deborah Birx, a Member of the White House Coronavirus Task